Details
Stereochemistry | MIXED |
Molecular Formula | C7H17N |
Molecular Weight | 115.2166 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C)CC(C)N
InChI
InChIKey=YAHRDLICUYEDAU-UHFFFAOYSA-N
InChI=1S/C7H17N/c1-4-6(2)5-7(3)8/h6-7H,4-5,8H2,1-3H3
Molecular Formula | C7H17N |
Molecular Weight | 115.2166 |
Charge | 0 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
METHYLHEXANEAMINE, an amphetamine derivative, is also known as 1,3-dimethylamylamine (DMAA). It was introduced in 1948 as a nasal inhaler for allergic or infectious rhinitis. By the 1970s, it had been withdrawn from the market. DMAA is currently used as an ingredient in many sports performance and weight loss products. According to FDA, it is not a dietary ingredient, and DMAA-containing products marketed as dietary supplements are illegal and their marketing violates the law.
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Forthane Approved UseMethylhexamine, a volatile sympathomimetic amine base, and its salts share the actions and uses of other vasoconstrictor agents. Methylhexamine is used as an inhalant for its local vasoconstrictor action on the nasal mucosa. This treatment produces temorary relief of nasal congestion and is used as an adjunct in the treatment of allergic or infectious rhinitis and sinusitis. For this purpose the drug is supplied in the form of the carbonate which readily releases the volatile base when the inhaler is opened. This method of local application of the drug produces little or no effect upon the pulse rate or blood pressure of adult humans. |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:24:40 GMT 2023
by
admin
on
Fri Dec 15 15:24:40 GMT 2023
|
Record UNII |
X49C572YQO
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
1141 (Number of products:5)
Created by
admin on Fri Dec 15 15:24:40 GMT 2023 , Edited by admin on Fri Dec 15 15:24:40 GMT 2023
|
||
|
WIKIPEDIA |
Designer-drugs-Methylhexanamine
Created by
admin on Fri Dec 15 15:24:40 GMT 2023 , Edited by admin on Fri Dec 15 15:24:40 GMT 2023
|
||
|
DSLD |
1227 (Number of products:65)
Created by
admin on Fri Dec 15 15:24:40 GMT 2023 , Edited by admin on Fri Dec 15 15:24:40 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3353
Created by
admin on Fri Dec 15 15:24:40 GMT 2023 , Edited by admin on Fri Dec 15 15:24:40 GMT 2023
|
PRIMARY | |||
|
7753
Created by
admin on Fri Dec 15 15:24:40 GMT 2023 , Edited by admin on Fri Dec 15 15:24:40 GMT 2023
|
PRIMARY | |||
|
8164
Created by
admin on Fri Dec 15 15:24:40 GMT 2023 , Edited by admin on Fri Dec 15 15:24:40 GMT 2023
|
PRIMARY | |||
|
X49C572YQO
Created by
admin on Fri Dec 15 15:24:40 GMT 2023 , Edited by admin on Fri Dec 15 15:24:40 GMT 2023
|
PRIMARY | |||
|
SUB182370
Created by
admin on Fri Dec 15 15:24:40 GMT 2023 , Edited by admin on Fri Dec 15 15:24:40 GMT 2023
|
PRIMARY | |||
|
105-41-9
Created by
admin on Fri Dec 15 15:24:40 GMT 2023 , Edited by admin on Fri Dec 15 15:24:40 GMT 2023
|
PRIMARY | |||
|
100000168769
Created by
admin on Fri Dec 15 15:24:40 GMT 2023 , Edited by admin on Fri Dec 15 15:24:40 GMT 2023
|
PRIMARY | |||
|
203-296-1
Created by
admin on Fri Dec 15 15:24:40 GMT 2023 , Edited by admin on Fri Dec 15 15:24:40 GMT 2023
|
PRIMARY | |||
|
METHYLHEXANAMINE
Created by
admin on Fri Dec 15 15:24:40 GMT 2023 , Edited by admin on Fri Dec 15 15:24:40 GMT 2023
|
PRIMARY | |||
|
1106
Created by
admin on Fri Dec 15 15:24:40 GMT 2023 , Edited by admin on Fri Dec 15 15:24:40 GMT 2023
|
PRIMARY | |||
|
m7427
Created by
admin on Fri Dec 15 15:24:40 GMT 2023 , Edited by admin on Fri Dec 15 15:24:40 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID60861715
Created by
admin on Fri Dec 15 15:24:40 GMT 2023 , Edited by admin on Fri Dec 15 15:24:40 GMT 2023
|
PRIMARY |